Literature DB >> 2327783

Bactericidal activities of various antimicrobial agents against human and animal isolates of Mycobacterium paratuberculosis.

R J Chiodini1.   

Abstract

The MICs and MBCs of various antimicrobial agents for strains of Mycobacterium paratuberculosis isolated from animal and human sources were evaluated. The MICs and MBCs of rifabutin, ciprofloxacin, ethambutol, clofazimine, streptomycin, cefazolin, and amikacin were found to be well below therapeutic levels in serum and tissue.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2327783      PMCID： PMC171590          DOI： 10.1128/AAC.34.2.366

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Mycobacterial disease: epidemiology, diagnosis, treatment, and prevention.

Authors:  A E Pitchenik; D Fertel; A B Bloch
Journal:  Clin Chest Med       Date:  1988-09       Impact factor: 2.878

2.  Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; W R Thayer; J A Coutu
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

Review 3.  Ruminant paratuberculosis (Johne's disease): the current status and future prospects.

Authors:  R J Chiodini; H J Van Kruiningen; R S Merkal
Journal:  Cornell Vet       Date:  1984-07

4.  Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides).

Authors:  H M McClure; R J Chiodini; D C Anderson; R B Swenson; W R Thayer; J A Coutu
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

5.  Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species.

Authors:  J J McFadden; P D Butcher; R Chiodini; J Hermon-Taylor
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

6.  Characterization of Mycobacterium paratuberculosis by gas-liquid and thin-layer chromatography and rapid demonstration of mycobactin dependence using radiometric methods.

Authors:  J J Damato; C Knisley; M T Collins
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

7.  In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; W R Thayer; J A Coutu; R S Merkal
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

8.  Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.

Authors:  P C Taylor; F D Schoenknecht; J C Sherris; E C Linner
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; R S Merkal; W R Thayer; J A Coutu
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

Review 10.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132
View more
  8 in total

Review 1.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis.

Authors:  S L Williams; N B Harris; R G Barletta
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 3.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo.

Authors:  N H Afdhal; A Long; J Lennon; J Crowe; D P O'Donoghue
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

5.  Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis.

Authors:  Stella Y Y Wong; Irene R Grant; Mendel Friedman; Christopher T Elliott; Chen Situ
Journal:  Appl Environ Microbiol       Date:  2008-08-01       Impact factor: 4.792

6.  Use of rifabutin in treatment of systemic Mycobacterium paratuberculosis infection in mice.

Authors:  R J Chiodini; J M Kreeger; W R Thayer
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 7.  Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; A Fitton
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

8.  RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis.

Authors:  Karel P Alcedo; Saisathya Thanigachalam; Saleh A Naser
Journal:  Gut Pathog       Date:  2016-06-14       Impact factor: 4.181
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.